Q1 EPS Forecast for Revolution Medicines Cut by Analyst

Chronological Source Flow
Back

AI Fusion Summary

HC Wainwright cut Revolution Medicines Q1 2026 EPS to $-1.82 from $-1.54, forecasting Q2 $-1.92, Q3 $-2.02, Q4 $-2.15, FY $-7.93. Sidoti trimmed Flexsteel Q3 2026 EPS to $0.75 from $0.80, projecting Q4 $0.70 and FY $3.94.
#HC_WAINRIGHT #REVOLUTION_MEDICINES #SIDOTI #FLEXSTEEL #EPS_FORECAST #Q1_2026 #Q3_2026
17/04 08:14 defenseworld.net
3 Πηγές

Q1 EPS Forecast for Revolution Medicines Cut by Analyst

EARTHQUAKEPOLITICSCOMPANIESANALYST ARTICLES - ESTIMATES
17/04 08:31 defenseworld.net

Q3 EPS Forecast for Flexsteel Industries Lowered by Analyst

COMPANIESANALYST ARTICLES - ESTIMATESPOLITICS
17/04 08:46 defenseworld.net

Q3 EPS Forecast for Helmerich & Payne Decreased by Analyst

ANALYST ARTICLES - ESTIMATESPOLITICSECONOMYCOMPANIES
Comments
Loading...
0